Tagged with R

pricing The president and chairman of MC Pharma discusses the position of the pharmacy segment in the current Moroccan healthcare context.  Could you introduce MC Pharma to our international readers, and more especially describe the relationship that exists between MC Pharma and Cooper Pharma? MC Pharma was established in 2002 by…

government ‘Poverty is fought with health, education and, above all, employment and more employment’. This is the vision Carlos Slim has for Mexico. The CEO of the Carlos Slim Foundation discusses how the foundation is actively involved in shaking up the system to bring innovation – and energy – to health.…

R&D “When I left Janssen, I never imagined joining a Korean company,” recalls Choi Tae-Hung, sipping a freshly brewed yujacha tea in his office on a crisp autumn morning as he gazes down at the busy, sundrenched streets of Seoul below. “I thought that the global business of Korean pharmaceutical companies…

regulator Flor de María Philipps, Superintendent of Susalud, discusses her role in ensuring that healthcare providers throughout Peru are performing to the best of their ability.   What is the main mission of Susalud? Our mission is to protect health-related rights of Peruvians. We are a public organization under the Ministry…

Bayer Worldwide, Bayer is experiencing a strong business momentum thanks to an avalanche of innovation. The general manager of Bayer HealthCare Pharmaceuticals in Mexico shares his perspectives about the recent developments of the market, how the company is partnering up with authorities to promote access and how the company is preparing…

generics After Brazil, Torrent is looking to strengthen its foothold in the Mexican market. The general manager of the local affiliate explains the opportunities Latin America offers to Indian companies, how – despite an apparent slackening performance – the Mexican pharmaceutical market is growing and how niche is the name of…

Exports The director general of Afric-Phar explains why it is difficult for the local players to compete with multinationals, how the Moroccan market is being reformed for the better and why companies should be looking to Africa to boost their growth prospects.   What are Afric-Phar’s strengths that make it an…

Sanofi The president and director general of Sanofi Morocco talks about the impact of public/private partnerships for the development of the Moroccan health sector, explains why 2013 was the African year for Sanofi and stresses the importance of visibility if Sanofi is to continue investing in large regional projects in the…

GSK Morocco has become GSK’s regional hub thanks to the quality of human capital in the country, explains the company’s area director, president and general manager for North Africa, who also comments on the reason why she remains optimistic for the future of Moroccan pharmaceutical industry.   We have heard from the industry…

Roche Ralf Halbach discusses the impact of low health coverage in Morocco on Roche’s strategy, and the fact that the company chose Morocco as the country to locate its northwest Africa management center.   You have been the head of Roche’s northwest Africa management center , as well as the general…

Novartis The country president and general director of Novartis Morocco discusses the impact of the price cuts on the pharma market, the need to change the health culture in the country and the importance of Morocco as a hub.   As well as being the country president of Novartis Morocco, you…

MOH Minister Moon discusses the results of his recent state visit to the Middle East with Korea’s President, and Korea’s assets and potential as a global healthcare partner in developing and pharmerging regions around the world.   Minister Moon, you just returned from a tour of the Middle East. Could you…